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Evaluation of desmin as a diagnostic and prognostic marker of childhood
rhabdomyosarcomas and embryonal sarcomas
P. Dias, P. Kumar, H.B. Marsden, P.H. Morris-Jones, J. Birch, R. Swindell & S. Kumar
Christie Hospital and Holt Radium Institute, Manchester M20 9BX, UK.
Summary The diagnostic and prognostic relevance of desmin expression in 80 rhabdomyosarcomas (RMS)
and 5 embryonal sarcomas (ES) was examined using a peroxidase anti-peroxidase staining procedure. Fifty-
nine RMS but only one ES stained for desmin (P<0.05). The maximum percentage of desmin containing cells
was 49 in RMS compared with only 1% in ES. Desmin positivity correlated inversely with survival (P<0.02)
in that RMS with high proportions of desmin positive cells were associated with poorer prognoses than those
containing fewer desmin positive cells. If the degree of expression of desmin is related to myogenic
differentiation, then our results indicate that poorly differentiated RMS tend to have a better prognosis than
the well differentiated tumours. One possible explanation is that the poorly differentiated RMS respond better
to chemotherapy than to well differentiated RMS. A multivariant analysis incorporating desmin staining,
treatment, histology, age and gender revealed that the two most significant independent prognostic factors
were treatment and histology.
Childhood rhabdomyosarcomas (RMS) are a heterogenous
group of tumours of skeletal muscle elements varying from
poorly differentiated to well differentiated forms. The
difficulty in diagnosis, especially of poorly differentiated
forms is well documented, and is often due to a lack of
observable features of skeletal muscle differentiation in the
tumour cells. Recently a number of skeletal muscle markers
have been introduced which aid the diagnosis of RMS (For
review see Roholl et al., 1986). Generally the expression of
most skeletal muscle markers depends on the degree of
differentiation of tumour cells. For instance, although
skeletal muscle myosin and myoglobin are highly specific
markers for the detection of skeletal muscle cell differen-
tiation in RMS, the use of these markers is limited to well
differentiated tumours. The alternative use of the muscle
isoenzyme of creatine kinase, which is expressed in a higher
proportion of poorly differentiated rhabdomyosarcomas (de
Jong et al., 1985 and personal communication), is somewhat
limited in that this isoenzyme is also expressed in leiomyo-
sarcomas, malignant fibrous histiocytomas, ganglioneuro-
blastomas, fibrosarcomas and liposarcomas (Wold et al.,
1981; de Jong et al., 1985; Roholl et al., 1986).
Although the presence of desmin in tumours has been
shown to vary from 32% to 100% in different studies (see
Table I), it is expressed in RMS of a wide spectrum of
differentiation and has consequently been advocated as a
reliable marker for distinguishing poorly differentiated RMS
from other small round cell tumours in childhood
(Altmannsberger et al., 1985; Harms et al., 1985; de Jong et
al., personal communication; Tsokos et al., personal com-
munication). Most of these studies however, were limited in
that they were carried out on relatively small numbers of
tumours. In addition none of these reports has actually
evaluated the prognostic relevance of desmin in RMS. In the
present study the reliability of desmin as a diagnostic and
prognostic marker has been examined in a large number of
childhood RMS.
Materials and methods
Tissues
Formalin fixed, paraffin embedded tumour specimens of 80
RMS and 5 embryonal sarcomas were stained with desmin
antibody (Table II). Haematoxylin and eosin (H&E) stained
sections of these tumours were examined and classified
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according to the system of the International Society of
Paediatric Oncology (SIOP) (Marsden 1985; & unpublished
data) (Table II).
The embryonal sarcomas included in this study were
histologically similar to RMS, although on routine staining
they showed no evidence of myoblastic differentiation such
as eccentric nuclei and eosinophilic cytoplasm.
Antisera
The rabbit polyclonal antibody to desmin (Euro Diagnostics,
Holland) was raised against chicken gizzard, affinity purified
and its specificity was established by immunoblotting and by
extensive testing using both frozen and paraffin embedded
tissues (Altmannsberger et al., 1985). It was diluted 1:25 for
staining. A monoclonal antibody to desmin was purchased
from Amersham International plc. UK and used at a
dilution of 1:10.
Staining procedures
A peroxidase anti-peroxidase (PAP) staining procedure was
carried out following the details given by Polak and Van
Noorden (1983). Sections were deparaffinized with xylene,
rehydrated in graded ethanols, washed with 0.1 M phosphate
buffered saline (PBS), pH 7.4, followed by thorough rinsing
with tap water. Endogenous peroxidase activity was inhibited
by treating sections with 0.5% hydrogen peroxide in
methanol. The sections were washed and incubated with a
1/20 dilution of normal swine serum (Sera-Labs, UK) for
15min. The excess normal blocking serum was drained off
and the sections incubated with desmin polyclonal antiserum
for 1 h, after which the sections were washed in 3 changes of
PBS (5 min each) and treated with a 1/50 dilution of swine
anti-rabbit immunoglobulin (Dakopatts, Mercia Brocades,
UK) for 30min. After washing in 3 changes of PBS, the
sections were incubated with a 1/40 dilution of rabbit
peroxidase anti-peroxidase complex (Dakopatts) for 30min
and finally washed in 3 changes of PBS. The colour was
developed using freshly prepared diaminobenzidine (DAB,
Sigma) as the chromogen. After thorough washing, the
sections were counterstained with haematoxylin, washed,
dehydrated and mounted.
For staining with desmin monoclonal antibody the indirect
immunoperoxidase method was used. Essentially the pro-
cedure was same as the PAP procedure except the reagents
substituted were a 1/20 dilution of normal rabbit serum,
followed by a 1/10 dilution of desmin monoclonal antibody
and finally by a 1/40 dilution of peroxidase conjugated
rabbit anti-mouse immunoglobulin (Dakopatts).
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Table I The results of desmin staining in rhabdomyosarcomas reported in the literature
Nos ofdesmin Per cent
positive tumours: desmin positive
Reference Total examined tumours
Kahn et al. (1983) 8/25 32
Molenaar et al. (1985) 17/21 81
Mordechai et al. (pers. comm.) 14/15 93
De Jong et al. (pers. somm.) 33/38 87
Tsokos et al. (pers. comm.) 11/11 100
Altmannsberger et al. (1985) 25/25 100
Present study 59/80 74
Staining of tumours was recorded as positive or negative.
Irrespective of the intensity of staining, the proportion of
positive cells was ascertained for each desmin positive
tumour by examining 10 randomly selected fields at a
magnification of x 700 using a Leitz microscope fitted with
an eye piece graticule. Between 500 and 700 cells were scored
as positive or negative for each slide and the results
expressed as the percentage of desmin-positive cells per
tumour.
The standard Kaplan and Meier statistical analysis
(Kaplan & Meier, 1958) was used for calculating and
projecting curves of overall survival. Statistical differences
between the survival curves were analysed by the log rank
test (Peto et al., 1977). These data were further analysed
using a multivariant analysis (Cox et al., 1972).
Results
None of the negative control tissue sections showed any
staining with normal rabbit serum (used alone without anti-
desmin antibody). For each tumour, identical staining results
were obtained using polyclonal and monoclonal antibodies
although the staining intensity was much stronger with the
former. For this reason, the percentages of desmin positive
tumour cells were scored on sections stained with polyclonal
antibody.
Fifty-nine of 80 (74%) of RMS were positive for desmin
compared with 1 of 5 ES (P<0.05, Fisher's exact test; Table
III & Figure 1 A-F). The percentage of desmin positive cells
per tumour varied from 0-49%. The mean percentage of
desmin positive cells for each sub-group ranged from 0.2 to
16.7% (Table IV). The intensity of the staining reaction
varied not only from tumour to tumour but also among
neoplastic cells in a given tumour in which both weakly and
strongly positive foci of cells were seen. Generally, a higher
proportion of well-differentiated tumour cells, such as strap
cells and multinucleated giant cells stained for desmin although
staining was also observed in some small, apparently
poorly differentiated tumour cells (Figure 1 A, B).
Table II Rhabdomyosarcomas and embryonal sarcomas (classified
as per International Society of Paediatric Oncology) used to stain
with desmin antibody
No.
Histological classification examined
A. Rhabdomyosarcomas
(i) Loose (botryoid and non-botryoid) 15
(ii) Dense (poor and good myoblastic differentiation) 43
(ii) Alveolar 19
(iv) Pleomorphic (adult type) 3
B. Embryonal sarcoma 5
TOTAL 85
Table III Results of desmin staining of 80 rhabdomyo-
sarcomas and 5 embryonal sarcomas
No. positive Per cent
desmin
No. examined positive
Histology
A. Rhabdomyosarcomas
(i) Loose 14/15 93
(ii) Dense 28/43 65
(iii) Alveolar 14/19 74
(iv) Pleomorphic (adult type) 3/3 100
59/80 74
B. Embryonal sarcomas 1/5 20
Table IV The results of desmin staining expressed as percentage of
desmin positive cells in rhabdomyosarcomas and embryonal
sarcomas
Percent positive
cells
Histology (Mean+s.d.) Median (range)
Loose 10.78+13.24 5.5 (0-49)
Dense 9.0 + 9.4 4 (0-32)
Alveolar 11.78+ 11.93 8 (0-36)
Pleomorphic (adult type) 16.66+ 7.7 17 (7-32)
Embryonal sarcoma 0.2 + 0.4 1 (0- 1)
Staining andprognosis
Figure 2A shows that although there was a trend towards
negatively stained tumours having a better prognosis than
positively stained tumours, the difference between the two
groups was not statistically significant. However, when the
tumours were graded according to the percentage of desmin
positive cells into four groups (0%, 1-4%, 5-19% and
20+%), a statistically significant difference in prognosis was
observed among them (P<0.02). The negatively stained
group (0%) and the group with only 1-4% desmin positive
cells had a better prognosis than those with higher
percentages (>5%) of desmin positive cells (Figure 2B).
There appeared to be a difference in prognosis between
the subgroups as regards histological classification (Figure 3)
although this was not statistically significant (P<0.06).
However, histology assumed significance (P<0.03) once
those patients receiving no chemotherapy (i.e. those
diagnosed prior to 1970) were excluded from the analysis. In
the present somewhat small series, gender and site had no
effect on prognosis (Figure 3).
A multivariant analysis incorporating desmin staining,
histology, age, sex, primary site of occurrence and chemo-
therapy as prognostic factors revealed that the two most
important independent prognostic factors were histological
classification and treatment.DESMIN IN RHABDOMYOSARCOMAS 363
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Figure 1 Immunoperoxidase staining of formalin fixed, paraffin embedded rhabdomyosarcomas (RMS) cells with desmin
antibody. a and b. Show staining with desmin antibody of an undifferentiated small round cell tumour. (a). Stained with the
desmin antibody. (b). H&E of the same tumour. (c). Strong staining of a well differentiated dense RMS. (d). Another well
differentiated RMS that stained intensely with the desmin antibody. It should be noted that this magnification was used for
assessing the percentage of desmin positive and negative cells. (e). Botryoid RMS containing many desmin positive cells. An
epithelial lining can be seen in the top left hand corner. (f). Botryoid RMS containing only a small percetage of desmin positive
cells.
Discussion
The aim of this study was to assess the reliability of desmin
as a diagnostic marker of rhabdomyosarcoma and to
evaluate its prognostic relevance. The staining result showed
that 74% (59 out of 80) rhabdomyosarcomas were positive
for desmin. When five embryonal sarcomas were included,
71% (60 of 85) of the tumours were positive for desmin. Our
desmin staining results are within the range reported in the
literature where the expression of desmin has been shown to
vary from 32 to 100 percent (see Table I). The variation in
positivity may be partly accounted for by the use of different
antibodies, the degree of differentiation of the tumours
examined (de Jong et al. 1985; Tsokos et al., personal
communication; Molenaar et al., 1985) and the method of
fixation and staining of the tumour specimens
(Altmannsberger et al., 1985; Molenaar et al., 1985). It
appears that formalin fixation may not be conducive to
immunostaining for desmin, especially in poorly differen-
tiated rhabdomyosarcomas. In their comparison of frozen
with formalin fixed RMS, Molenaar et al. (1985) concluded
that the latter is inadequate for demonstrating minimal
amounts of desmin. In the desmin positive tumours in our
series, a higher proportion of well differentiated tumour cells
stained for desmin whereas most of the poorly differentiated
tumour cells were negative. It is likely that some of these
negatively stained cells may have expressed minimal amounts
of desmin which were not detected after formalin fixation.
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Figure 2 Life Table: Survival in years. (a). Desmin staining and survival in RMS: (a) desmin negative (b) desmin positive. (b).
Percent desmin staining cells and survival: RMS with (a) 0% desmin positive cells (b) 1-4% desmin positive cells and (c) >5%
desmin positive cells.
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Figure 3 Life Tables: Survival in years. (a). Histology (SIOP classifications) and survival: (a) loose RMS (b) embryonal sarcoma
(c) alveolar RMS (d) dense RMS and (e) pleomorphic RMS. (b). Age and survival (a) >3 year (b) <1 year and (c) 1-3 years. (c).
Gender and survival: (a) male and (b) female. (d). Site and survival: (a) head and neck (b) trunk (c) extremities.
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This might also have been the case with the totally desmin
negative tumours.
The mean percentages of desmin positive cells in the
subgroups of RMS varied from 9.0 to 16.7 percent. The
highest percentage (16.7%) was found in the pleomorphic,
and the lowest (9.0) in dense RMS, however these differences
were not significant. Since there are no reports on the actual
quantitation of desmin containing cells in RMS, it is not
possible to compare our results with the published literature.
It is noteworthy that only one of the 5 ES was desmin
positive and the percentage of positive cells was low (1.0%).
Thus, the rarity of desmin positive cells in ES agrees with the
histological classification i.e. lends support to the separation
of ES from RMS.
There was a trend towards desmin negative tumours
having a better prognosis, although the difference between
the survival curves was not statistically significant. However,
it was found that the two groups with 0% and 1-4% desmin
positive cells had a better prognosis than those with a higher
percentage of cells staining (5+ %). Thus the results of this
study appear to indicate that there is an inverse correlation
between the number of cells expressing desmin in RMS and
prognosis. The multivariant analysis established that this was
not an independent prognostic factor, whereas histological
classification and chemotherapy were.
Some studies support the association of histology with
prognosis whereas others maintain that histology is not a
prognostic factor (for review see Triche, 1982 and Favara et
al., 1986). The published literature indicates that desmin-
positivity in RMS is associated with cytological differen-
tiation. Molenaar et al. (1985) noted that the differences in
staining observed between their poorly, moderately and well
differentiated RMS reflected quantitative differences in the
expression of desmin. Therefore, if desmin is utilised as a
marker of myogenic differentiation, the results of this study
would indicate that poorly differentiated rhabdomyo-
sarcomas tend to have a better prognosis than well differen-
tiated tumours. Molenaar et al. (1984) concluded that the
major role of chemotherapy in RMS was the selective
destruction of undifferentiated tumour cells and similar
findings have been reported by Harms et al. (1985).
Therefore, the better prognosis of desmin negative RMS
noted by us might be due to the fact that poorly differen-
tiated rhabdomyosarcomas respond better to chemotherapy
with the majority of their (undifferentiated) cells being
selectively killed probably because they are in continuous cell
cycle. The more differentiated tumours may be relatively
resistant to chemotherapy in that most of their cells would
be cycling more slowly and would not be killed. Further
studies involving the use of other markers for RMS differ-
entiation and proliferation need to be undertaken to
extablish the validity of this hypothesis. It is interesting that
an inverse relationship between differentiation and survival
has also been noted in medullablastoma. Thus, Latchaw et
al. (1985) reported that tumours showing no differentiation
had four year survival rate of 70% compared with 32% for
those showing differentiation.
Technical assistance of Mrs Joan Ashworth is most gratefully
acknowledged.
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